ED90 of Norepinephrine and Phenylephrine Infusions Under Intensive Treatment

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Adverse Effect
Interventions
DRUG

Norepinephrine

An initial infusion dose of prophylactic norepinephrine (0.05 ug/kg/min) simultaneous with spinal anesthesia. The dose administered to subsequent patients varied by increments or decrements of 0.01 ug/kg/min of prophylactic norepinephrine according to the responses of previous patients according to the up-down sequential allocation.

DRUG

Phenylephrine

An initial infusion dose of prophylactic phenylephrine (0.5 ug/kg/min) simultaneous with spinal anesthesia. The dose administered to subsequent patients varied by increments or decrements of 0.1 ug/kg/min of prophylactic phenylephrine according to the responses of previous patients according to the up-down sequential allocation.

Trial Locations (1)

750004

General Hospital of Ningxia Medical University, Yinchuan

All Listed Sponsors
lead

General Hospital of Ningxia Medical University

OTHER

NCT06158048 - ED90 of Norepinephrine and Phenylephrine Infusions Under Intensive Treatment | Biotech Hunter | Biotech Hunter